Login / Signup

Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg).

Ángeles Pérez-AisaOlga P NyssenAlma Keco-HuergaLuís RodrigoAlfredo J LucendoBlas J Gomez-RodriguezJuan OrtuñoMónica PeronaJosé María HuguetOscar NúñezLuis Fernandez-SalazarJesus BarrioAngel LanasEduardo IyoPilar Mata RomeroMiguel Fernández-BermejoBarbara GomezAna GarreJudith Gomez-CamareroLuis Javier LamuelaAna CampilloLuisa de la Peña-NegroManuel Dominguez CajalLuis BujandaDiego Burgos-SantamaríaFernando BermejoVíctor González-CarreraRamón PajaresPedro Almela NotariJavier Tejedor-TejadaMontserrat PlanellaItxaso JiménezYolanda Arguedas LázaroAntonio Cuadrado-LavínIsabel Pérez-MartínezEdurne AmorenaJesús M Gonzalez-SantiagoTeresa AngueiraVirginia FloresSamuel J Martínez-DomínguezManuel Pabón-CarrascoBenito VelayosAlicia AlgabaConsuelo RamírezEnrique Alfaro AlmajanoManuel Castro-FernandezNoelia AlcaidePatricia Sanz SeguraAnna Cano-CatalàNatalia García-MoralesLeticia MoreiraFrancis MégraudColm O'MorainXavier Calvet CalvoFrancisco Javier García-Alonso
Published in: Gut (2023)
ScBQT prescribed three times a day was more effective than the traditional four times a day schedule. No differences were observed in treatment adherence or safety.
Keyphrases
  • helicobacter pylori
  • helicobacter pylori infection
  • randomized controlled trial
  • systematic review
  • type diabetes
  • skeletal muscle
  • adipose tissue
  • combination therapy
  • replacement therapy
  • visible light